Cevostamab (BFCR4350A, RG6160, RO7187797) is a humanized bispecific antibody targeting FcRH5/CD3. It binds to FcRH5 expressed on multiple myeloma (MM) cells and CD3 on T cells, promoting T cell synapse formation and inhibiting B-cell malignancies.
Purity:
95.10%
CAS Number:
[2249888-53-5]
Target:
Integrin|||Immunology/Inflammation related
* VAT and and shipping costs not included. Errors and price changes excepted